Biovie Inc
(BIVI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,541 | 24,978 | 17,545 | 23,152 | 24,406 |
| Receivables | 196 | 180 | 2,104 | N/A | N/A |
| Other current assets | 1,055 | 874 | 1,050 | 570 | 276 |
| TOTAL | $21,791 | $26,032 | $20,699 | $23,722 | $24,681 |
| Non-Current Assets | |||||
| Intangibles | 409 | 467 | 524 | 581 | 639 |
| Other Non-Current Assets | 303 | 321 | 340 | 357 | 374 |
| TOTAL | $712 | $788 | $864 | $939 | $1,013 |
| Total Assets | $22,503 | $26,820 | $21,562 | $24,660 | $25,694 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,923 | 1,566 | 2,200 | 2,476 | 1,383 |
| Other current liabilities | N/A | N/A | N/A | N/A | 7 |
| TOTAL | $3,006 | $1,645 | $2,275 | $2,547 | $1,457 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 233 | 254 | 275 | 296 | 315 |
| TOTAL | $233 | $254 | $275 | $296 | $315 |
| Total Liabilities | $3,238 | $1,899 | $2,550 | $2,842 | $1,772 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,544 | 7,540 | 7,534 | 1,856 | 1,845 |
| Common Shares | 1 | 1 | 0 | 8 | 8 |
| Retained earnings | -363,345 | -357,275 | -352,144 | -348,655 | -345,867 |
| TOTAL | $19,265 | $24,921 | $19,012 | $21,818 | $23,923 |
| Total Liabilities And Equity | $22,503 | $26,820 | $21,562 | $24,660 | $25,694 |